Advancing Knowledge. Enhancing Care.
Advancing Knowledge. Enhancing Care.

Psoriasis News

the latest news from ipc, industry and others

Contributing writer

Thomas Scharnitz, MD
University of MIchigan
Ann Arbor, MI,

Thomas Scharnitz received his medical degree at Pennsylvania State University and completed his intern year in internal medicine at the University of Virginia. He is currently in his third year of training as a resident physician at the University of Michigan Department of Dermatology.

Last Updated: Dec 06, 2018

Psoriasis News

3/31/2020 10:15:00 AM
Lilly's TALTZ® (IXEKIZUMAB) receives U.S. FDA approval for the treatment of pediatric patients with moderate to severe plaque psoriasis
3/11/2020 1:09:00 PM
For psoriasis patients diagnosed with COVID-19 disease, the IPC recommends physicians discontinue or postpone use of immunosuppressant medications. This is in accordance with established psoriasis treatment guidelines, which state immunosuppressive psoriasis treatments are contraindicated in patients with active infections.
2/6/2020 10:54:00 AM
Just published - IPC's latest issue of the Psoriasis Review newsletter is now available! This issue features the Top Five Papers in psoriasis research, symposia reports, IPC news, and more!
2/6/2020
More News

We use cookies on this website to enhance your experience. By continuing with this website, you consent to our use of cookies. Learn more.
OK